Kanaga Sabapathy

Professor Sabapathy is the Chair of the School of Biological Sciences (SBS). He is also the President’s Chair in Biological Sciences. Prof Sabapathy recently joined NTU from the National Cancer Centre Singapore (NCCS), where he headed the Division of Cellular & Molecular Research. He obtained his B.Sc.(Hons) degree in Zoology from the National University of Singapore, and his Ph.D. in Molecular & Cellular Immunology from the Institute for Molecular & Cellular Biology, Singapore, in 1995. His post-doctoral work was conducted at the Institute of Molecular Pathology (Vienna, Austria), studying cellular signaling using genetically modified mice. He moved to the NCCS in late 1999 as the Principal Investigator of the Laboratory of Molecular Carcinogenesis, and since 2013, was the overall Head of the Research Division. Dr Sabapathy was concurrently also a Professor and Deputy Program Director of the Cancer and Stem Cell Biology Program at Duke-NUS, and the Research Director of the Academic Clinical Program in Oncology at SingHealth/Duke-NUS. In May 2023, Prof Sabapathy joined NTU to become the President’s Chair Professor and Chair of the School of Biological Sciences. He is a Fellow of the Royal College of Pathologists (UK), and a recipient of the inaugural National Research Foundation Investigatorship award. Prof Sabapathy is an accomplished cancer researcher with more than 32 years of experience in the healthcare, scientific and tertiary education sectors. Recognised as an opinion leader in his field, he has a strong track record of securing large competitive grants from major sources such as the National Medical Research Council and National Research Foundation Singapore. He has published over 95 articles and book chapters in peer-reviewed journals, filed seven patents and applications, and received honours for his outstanding research contributions. He is a member of the scientific advisory boards of the National Foundation for Cancer Research in the United States and the Hong Kong-based Asian Fund for Cancer Research.